Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-11-04A Phase II Study Exploring the Safety, Tolerability and Preliminary Anti-tumor Activity of Sitravatinib With or Without Tislelizumab in Patients With Unresectable or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2021-10-29A Phase I/II Trial of Vemurafenib and Metformin to Unresectable Stage IIIC and Stage IV BRAF.V600E+ Melanoma Patients
-
CLINICAL_TRIALS study record update · 2021-10-28Perioperative Encorafinib+Binimetinib in BRAFV600 Mutant Clinically Detected AJCC Stage III (B/C/D) or Oligometastatic Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2021-10-26A Randomized Trial Evaluating the Use of Fibrin Tissue Adhesive Following Axillary Node Dissection in Patients With Melanoma
-
CLINICAL_TRIALS study record update · 2021-10-22PRAME Immunohistochemistry as an Adjunct for Evaluating Ambiguous Melanocytic Proliferation
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-10-18A Phase 1 Study of TRAIL-DR5 Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Unresectable Stage III or Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2021-10-06Phase II Randomized, Parallel-Group Trial on PTK-ZK With or Without DTIC in Patients With Non-resectable Metastatic Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2021-10-05A Multi-Center Phase 2 Open-Label Study to Evaluate Safety and Efficacy in Subjects With Melanoma Metastatic to the Brain Treated With Nivolumab in Combination With Ipilimumab Followed by Nivolumab Monotherapy
-
CLINICAL_TRIALS study record update · 2021-09-30Feasibility Study of Biomarker-driven Therapy Based on a Comprehensive Molecular Analysis of Tumor Tissue and Blood Collections in Melanoma
-
CLINICAL_TRIALS study record update · 2021-09-29Open Label Multicenter Phase I/II Study of the Safety and Efficacy of PDR001 Administered to Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2021-09-20Myeloid and Plasmacytoid Blood Dendritic Cells for Immunotherapy of Stage III Melanoma Patients
-
CLINICAL_TRIALS study record update · 2021-09-16Neoadjuvant Phase II Study of TLR9 Agonist CMP-001 in Combination With Nivolumab in Stage IIIB/C/D Melanoma Patients With Clinically Apparent Lymph Node Disease
-
CLINICAL_TRIALS study record update · 2021-09-14An Observational Study in Patients Receiving Adjuvant Nivolumab Therapy for Resected Melanoma
-
CLINICAL_TRIALS study record update · 2021-09-14Two-years Follow-up of Melanoma Patients Treated by Nivolumab During the French ATU Program
-
CLINICAL_TRIALS study record update · 2021-08-24A Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Recombinant Humanized Monoclonal Antibody Specific to B- and T- Lymphocyte Attenuator, BTLA (JS004) Injection in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2021-08-17A Phase II Study of Concurrent Dabrafenib and Trametinib With Stereotactic Radiation in the Management of Patients With BRAF Mutation-Positive Malignant Melanoma and Brain Metastases
-
CLINICAL_TRIALS study record update · 2021-08-13Impact of an Artificial Intelligence Platform (DERM) on the Healthcare Resource Utilisation (HRU) Needed to Diagnose Skin Cancer When Used as Part of a United Kingdom-based Teledermatology Service
-
CLINICAL_TRIALS study record update · 2021-08-13Activation of pDCs at the Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist
-
CLINICAL_TRIALS study record update · 2021-08-11A Phase Ib/II, Open Label, Multicenter Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2021-08-03Camrelizumab Combined With Anlotinib and Nab-paclitaxel in Patients With Untreated Advanced Mucosal Melanoma:a Single-arm, Multicenter, Open-label Study
-
CLINICAL_TRIALS study record update · 2021-08-02Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief
-
CLINICAL_TRIALS study record update · 2021-07-22A Phase 3, Randomized Study of Adjuvant Immunotherapy With Nivolumab Combined With Ipilimumab Versus Nivolumab Monotherapy After Complete Resection of Stage IIIb/c/d or Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2021-07-16Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
-
CLINICAL_TRIALS study record update · 2021-07-12A 2-part Phase III Randomized, Open Label, Multicenter Study of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma
-
CLINICAL_TRIALS study record update · 2021-07-09A Phase 3, Randomized, Double-blind Study of BMS-986205 Combined With Nivolumab Versus Nivolumab in Participants With Metastatic or Unresectable Melanoma That is Previously Untreated